Ovarian Neoplasms
Oncology·MeSH: Ovarian Neoplasms
Prevalence
24.0 / 100K
Incidence
10.6 / 100K/yr
8 drugs in development·4 companies·13 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Ovarian Neoplasms?
BioSniper tracks 8 drugs in development for Ovarian Neoplasms across 4 companies.
How many clinical trials target Ovarian Neoplasms?
There are 13 clinical trials targeting Ovarian Neoplasms tracked by BioSniper.
What is the prevalence of Ovarian Neoplasms?
The estimated prevalence of Ovarian Neoplasms is approximately 24.0 per 100,000 population.
Deep-dive into Ovarian Neoplasms
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis